These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 33692750)
1. Chenodeoxycholic Acid Modulates Bile Acid Synthesis Independent of Fibroblast Growth Factor 19 in Primary Human Hepatocytes. Johansson H; Søndergaard JN; Jorns C; Kutter C; Ellis ECS Front Endocrinol (Lausanne); 2020; 11():554922. PubMed ID: 33692750 [TBL] [Abstract][Full Text] [Related]
2. Bile acids activate fibroblast growth factor 19 signaling in human hepatocytes to inhibit cholesterol 7alpha-hydroxylase gene expression. Song KH; Li T; Owsley E; Strom S; Chiang JY Hepatology; 2009 Jan; 49(1):297-305. PubMed ID: 19085950 [TBL] [Abstract][Full Text] [Related]
3. Feedback regulation of bile acid synthesis in primary human hepatocytes: evidence that CDCA is the strongest inhibitor. Ellis E; Axelson M; Abrahamsson A; Eggertsen G; Thörne A; Nowak G; Ericzon BG; Björkhem I; Einarsson C Hepatology; 2003 Oct; 38(4):930-8. PubMed ID: 14512880 [TBL] [Abstract][Full Text] [Related]
4. Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man. Lundåsen T; Gälman C; Angelin B; Rudling M J Intern Med; 2006 Dec; 260(6):530-6. PubMed ID: 17116003 [TBL] [Abstract][Full Text] [Related]
5. Potency of individual bile acids to regulate bile acid synthesis and transport genes in primary human hepatocyte cultures. Liu J; Lu H; Lu YF; Lei X; Cui JY; Ellis E; Strom SC; Klaassen CD Toxicol Sci; 2014 Oct; 141(2):538-46. PubMed ID: 25055961 [TBL] [Abstract][Full Text] [Related]
6. Potent stimulation of fibroblast growth factor 19 expression in the human ileum by bile acids. Zhang JH; Nolan JD; Kennie SL; Johnston IM; Dew T; Dixon PH; Williamson C; Walters JR Am J Physiol Gastrointest Liver Physiol; 2013 May; 304(10):G940-8. PubMed ID: 23518683 [TBL] [Abstract][Full Text] [Related]
7. Chenodeoxycholic acid significantly impacts the expression of miRNAs and genes involved in lipid, bile acid and drug metabolism in human hepatocytes. Krattinger R; Boström A; Lee SML; Thasler WE; Schiöth HB; Kullak-Ublick GA; Mwinyi J Life Sci; 2016 Jul; 156():47-56. PubMed ID: 27174168 [TBL] [Abstract][Full Text] [Related]
8. Effect of cholecystectomy on bile acid synthesis and circulating levels of fibroblast growth factor 19. Barrera F; Azócar L; Molina H; Schalper KA; Ocares M; Liberona J; Villarroel L; Pimentel F; Pérez-Ayuso RM; Nervi F; Groen AK; Miquel JF Ann Hepatol; 2015; 14(5):710-21. PubMed ID: 26256900 [TBL] [Abstract][Full Text] [Related]
9. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Schaap FG; van der Gaag NA; Gouma DJ; Jansen PL Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005 [TBL] [Abstract][Full Text] [Related]
10. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes. Petrov PD; Fernández-Murga L; Conde I; Martínez-Sena T; Guzmán C; Castell JV; Jover R Arch Toxicol; 2020 Feb; 94(2):589-607. PubMed ID: 31894354 [TBL] [Abstract][Full Text] [Related]
11. Suppression of bile acid synthesis by thyroid hormone in primary human hepatocytes. Ellis EC World J Gastroenterol; 2006 Aug; 12(29):4640-5. PubMed ID: 16937432 [TBL] [Abstract][Full Text] [Related]
12. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. Hu X; Bonde Y; Eggertsen G; Rudling M J Intern Med; 2014 Jan; 275(1):27-38. PubMed ID: 24118394 [TBL] [Abstract][Full Text] [Related]
13. An FXR Agonist Reduces Bile Acid Synthesis Independently of Increases in FGF19 in Healthy Volunteers. Al-Khaifi A; Rudling M; Angelin B Gastroenterology; 2018 Oct; 155(4):1012-1016. PubMed ID: 29928896 [TBL] [Abstract][Full Text] [Related]
14. Bile acids and cytokines inhibit the human cholesterol 7 alpha-hydroxylase gene via the JNK/c-jun pathway in human liver cells. Li T; Jahan A; Chiang JY Hepatology; 2006 Jun; 43(6):1202-10. PubMed ID: 16729332 [TBL] [Abstract][Full Text] [Related]
15. Bile acid signal-induced phosphorylation of small heterodimer partner by protein kinase Cζ is critical for epigenomic regulation of liver metabolic genes. Seok S; Kanamaluru D; Xiao Z; Ryerson D; Choi SE; Suino-Powell K; Xu HE; Veenstra TD; Kemper JK J Biol Chem; 2013 Aug; 288(32):23252-63. PubMed ID: 23824184 [TBL] [Abstract][Full Text] [Related]
16. A putative role of micro RNA in regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes. Song KH; Li T; Owsley E; Chiang JY J Lipid Res; 2010 Aug; 51(8):2223-33. PubMed ID: 20351063 [TBL] [Abstract][Full Text] [Related]
17. Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption. Kim YC; Byun S; Seok S; Guo G; Xu HE; Kemper B; Kemper JK Gastroenterology; 2019 Mar; 156(4):1052-1065. PubMed ID: 30521806 [TBL] [Abstract][Full Text] [Related]
18. No Gut No Gain! Enteral Bile Acid Treatment Preserves Gut Growth but Not Parenteral Nutrition-Associated Liver Injury in a Novel Extensive Short Bowel Animal Model. Villalona G; Price A; Blomenkamp K; Manithody C; Saxena S; Ratchford T; Westrich M; Kakarla V; Pochampally S; Phillips W; Heafner N; Korremla N; Greenspon J; Guzman MA; Kumar Jain A JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1238-1251. PubMed ID: 29701901 [TBL] [Abstract][Full Text] [Related]
19. Effects of chenodeoxycholic acid on the secretion of gut peptides and fibroblast growth factors in healthy humans. Meyer-Gerspach AC; Steinert RE; Keller S; Malarski A; Schulte FH; Beglinger C J Clin Endocrinol Metab; 2013 Aug; 98(8):3351-8. PubMed ID: 23783097 [TBL] [Abstract][Full Text] [Related]
20. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge. Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]